Skip to main content
IRS-authorized e-file provider · not the IRS

Nonprofit · EIN 27-0341021

FIBROLAMELLAR CANCER FOUNDATION

Tax-exempt · GREENWICH, CT 06830

Financials

$3M$5.5M2023$3.4M$2.9M2024
Revenue Expenses · by fiscal year end
Financials of FIBROLAMELLAR CANCER FOUNDATION by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$3,413,883$2,853,234$560,649$10,229,754$3,307,756$6,921,998
December 31, 2023990$2,960,135$5,485,040-$2,524,905$10,499,605$4,097,846$6,401,759
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$3,088,534
Program service revenue
$0
Investment income
$325,349
Net gain from sales of assets
$169,997
Other revenue
$0

Expenses

Grants and similar amounts paid
$1,654,708
Compensation of officers, directors and key employees
$250,500
Other salaries and wages
$400,336
Salaries, compensation and benefits (total)
$789,038
Professional fundraising fees
$0
Travel
$2,374
Program services (functional)
$2,338,262
Management and general (functional)
$485,364
Fundraising (functional)
$29,608

Balance sheet and other

Total assets, start of year
$10,499,605
Total assets, end of year
$10,229,754
Total liabilities, end of year
$3,307,756
Net assets, end of year
$6,921,998
Net assets without donor restrictions
$6,921,998
Gross receipts
$3,683,771
Employees
4
Volunteers
50
Year formed
2009
State of legal domicile
DE

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
KURT LOSERTCEO
Trustee or director, Officer
40$250,500$10,295
DR MARK FURTHCHIEF SCIENCE OFFICER
Highest-paid employee
40$165,271$6,935
PAYAL RAYPROGRAM RESEARCH DIRECTOR
Highest-paid employee
40$153,656$5,956
MARNA O DAVISCO-CHAIRPERSON
Trustee or director, Officer
25$0$0
CHARLES W BEERMANNDIRECTOR
Trustee or director
1$0$0
DEREK GILCHRISTDIRECTOR, SECRETARY
Trustee or director, Officer
2$0$0
ANNE ADLERDIRECTOR
Trustee or director
25$0$0
JOHN CRAIGDIRECTOR
Trustee or director
1$0$0
TAL FRIEDMANDIRECTOR
Trustee or director
1$0$0
CHARLES A DAVISCO-CHAIRPERSON
Trustee or director, Officer
1$0$0
LESLIE GRAVESTREASURER
Trustee or director, Officer
1$0$0
CRAIG MARTINDIRECTOR
Trustee or director
1$0$0
GUY LEVYDIRECTOR
Trustee or director
1$0$0
990 for the year ended December 31, 2023: 14 people
NameTitleHours / weekCompensationOther / benefits
KURT LOSERTCEO
Trustee or director, Officer
40$273,188$6,793
DR MARK FURTHSCIENTIFIC DIRECTOR
Highest-paid employee
40$159,650$6,777
JOHN HOPPERDIRECTOR(RETIRED 05/23)
Former
1$88,718$3,711
MARNA O DAVISCO-CHAIRPERSON
Trustee or director, Officer
25$0$0
CHARLES W BEERMANNDIRECTOR
Trustee or director
1$0$0
DEREK GILCHRISTDIRECTOR, SECRETARY
Trustee or director, Officer
2$0$0
ANNE ADLERDIRECTOR
Trustee or director
25$0$0
JOHN CRAIGDIRECTOR
Trustee or director
1$0$0
TAL FRIEDMANDIRECTOR
Trustee or director
1$0$0
CHARLES A DAVISCO-CHAIRPERSON
Trustee or director, Officer
1$0$0
LESLIE GRAVESTREASURER
Trustee or director, Officer
1$0$0
CRAIG MARTINDIRECTOR
Trustee or director
1$0$0
DAVID WERMUTHDIRECTOR
Trustee or director
1$0$0
GUY LEVYDIRECTOR
Trustee or director
1$0$0

Address and contacts

Address (IRS master file)
20 HORSENECK LANE 2ND FLOOR, GREENWICH, CT 06830-6327
In care of
% JOHN HOPPER
Principal officer (990 for 2024)
KURT LOSERT, 14 WHITE OAK ROAD, WELLESLEY, MA 02481
Signed the 990
KURT LOSERT, CEO
Phone
(203) 340-7800
Return prepared by
EISNER ADVISORY GROUP LLC

Mission

FIBROLAMELLAR CANCER FOUNDATION,(THE "FOUNDATION") WAS ESTABLISHED TO RAISE AWARENESS AND RESEARCH FUNDS FOR FIBROLAMELLAR CARCINOMA, A RARE FORM OF LIVER CANCER THAT IS PRIMARILY SEEN IN TEENS AND YOUNG ADULTS. CURRENTLY, THERE ARE NO VIABLE TREATMENT OPTIONS OTHER THAN LIVER RESECTION SURGERY. OUR MISSION IS TO FIND A CURE AND RELIABLE TREATMENT OPTIONS FOR THOSE DIAGNOSED WITH THIS RARE DISEASE AS WELL AS ENHANCE COMMUNICATIONS AMONG HEALTHCARE PROFESSIONALS AND PATIENTS.

990 for the year ended December 31, 2024

Program accomplishments

  • GRANTS TO RESEARCH ORGANIZATIONS FOR FIBROLAMELLAR CARCINOMA STUDIES.
    Expenses $2,338,262 · grants $1,654,708

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
27-0341021
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2010
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$10,229,754
Income (IRS master file)
$3,683,771

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$3,413,883$2,853,234$10,229,754XML
990December 2023$2,960,135$5,485,040$10,499,605XML
990December 2022$6,076,635$2,563,688$10,981,422IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 27-0341021).

Questions about FIBROLAMELLAR CANCER FOUNDATION

What is the EIN of FIBROLAMELLAR CANCER FOUNDATION?
The employer identification number (EIN) of FIBROLAMELLAR CANCER FOUNDATION is 27-0341021.
Is FIBROLAMELLAR CANCER FOUNDATION tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2010.
Are donations to FIBROLAMELLAR CANCER FOUNDATION tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does FIBROLAMELLAR CANCER FOUNDATION file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of FIBROLAMELLAR CANCER FOUNDATION due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did FIBROLAMELLAR CANCER FOUNDATION last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of FIBROLAMELLAR CANCER FOUNDATION?
The 990 for the year ended December 31, 2024 names KURT LOSERT.
Who are the officers and directors of FIBROLAMELLAR CANCER FOUNDATION?
The 990 for the year ended December 31, 2024 lists 13 people; 3 received compensation from the organization, the highest $250,500 (KURT LOSERT, CEO).
How much revenue does FIBROLAMELLAR CANCER FOUNDATION have?
On its 990 for the year ended December 31, 2024 it reported revenue of $3,413,883, expenses of $2,853,234 and total assets of $10,229,754 at year end.

Other nonprofits in GREENWICH

All nonprofits in GREENWICH · Connecticut · Voluntary health associations and medical disciplines